A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning

Novelty in the field of oncology. The CHUV is testing a promising radiotherapy against cancer.

Welcome to Prof. Christoph Merten, head of the biomedical microfluidics laboratory at AGORA, an essential link in the development of new drugs.

The Pierre-François Leyvraz Award was created by the ISREC Foundation to honor Prof. Pierre-François Leyvraz’ commitment within its Foundation…

The ISREC Foundation, celebrating its 56th anniversary this month, is developing its activities at the heart of the AGORA cancer research cluster. The…